α1-receptor blockers combined with acupuncture treatment efficacy analysis of elderly patients with acute urinary retention

Objective To explore acupuncture and al-receptor blocker treatment efficacy of elderly patients with acute urinary retention. Methods Use of forward-looking monitoring and retrospective survey methodology, Choose January 1,2006 to January 1,2009 of acute urinary retention in 82 cases of elderly inpatients,Chronological order according to treatment group,39 cases were divided into control group,43 cases; Transurethral catheterization in both groups, stay catheter. The control group was treated with α1-receptor blocker hytrin (terazosin) and the application of antibiotics; the treatment group based on the above plus acupuncture therapy. Results The treatment group was 94.87% in the control group response rate was 76.74%, the two groups,P<0.05, the difference was significant. Conclusion al-receptor blockers combined with acupuncture treatment of elderly patients with acute urinary retention al-receptor blocker than simply good effects, synergistic effect, shortening the indwelling catheter time, avoid repeated urinary catheterization and reduce hospital infection, worthy to be popularized.     

α1-receptor blockers combined with acupuncture treatment efficacy analysis of elderly patients with acute urinary retention

Objective To explore acupuncture and al-receptor blocker treatment efficacy of elderly patients with acute urinary retention. Methods Use of forward-looking monitoring and retrospective survey methodology, Choose January 1,2006 to January 1,2009 of acute urinary retention in 82 cases of elderly inpatients,Chronological order according to treatment group,39 cases were divided into control group,43 cases; Transurethral catheterization in both groups, stay catheter. The control group was treated with α1-receptor blocker hytrin (terazosin) and the application of antibiotics; the treatment group based on the above plus acupuncture therapy. Results The treatment group was 94.87% in the control group response rate was 76.74%, the two groups,P<0.05, the difference was significant. Conclusion al-receptor blockers combined with acupuncture treatment of elderly patients with acute urinary retention al-receptor blocker than simply good effects, synergistic effect, shortening the indwelling catheter time, avoid repeated urinary catheterization and reduce hospital infection, worthy to be popularized.     

电刺激联合综合护理干预对女性压力性尿失禁的效果研究

目的 探讨电刺激联合综合护理干预对女性压力性尿失禁的治疗效果.方法 选择2008年1～12月48例女性压力性尿失禁患者,随机分为对照组和干预组各24例.采用类实验性研究设计,对照组接受电刺激治疗,干预组接受电刺激联合综合护理干预,在干预第8周和第12周分别对2组的盆底肌力、1 h尿垫试验漏尿量、主观尿失禁等级评分和生活质量等方面进行评价.结果 干预组患者较对照组而言,虽然主观尿失禁等级评分没有显著差异,但是盆底肌力和生活质量有明显改善,漏尿量显著减少.结论 电刺激联合综合护理干预是治疗女性压力性尿失禁的有效方式.

Abstract：

Objective To investigate the effectiveness of the combined electrical stimulation and nursing interventions for female stress urinary incontinence.Methods The study is qusi-experimental design.48 patients with stress urinary incontinence were allocated to the intervention group and the control group with 24 patients in each group.The control group was given electrical stimulation,the intervention group was given 12-week electrical stimulation and comprehensive nursing interventions.The outcome indicators were 1-hour pad test urine loss,pelvic floor muscle (PFM) strength,the grade of subjective urinary incontinence,quality of life (I-QOL).Results Compared with the control group,no significant subjective urinary incontinence score was seen,but pelvic floor muscle (PFM ) strength and the score of the QOL evidently improved and 1-hour pad test urine loss decreased in the intervention group.Conclusions Combined electrical stimulation and nursing interventions for female stress urinary incontinence is effective treatment.     

The clinical values of ultra-early enteral nutrition combined with microecopharmaceutics on patients with severe acute pancreatitis北大核心CSCD

Objective: To analyze the clinical values of super early enteral nutrition combined with microecopharmaceutics and delayed enteral nutrition on patients with severe acute pancreatitis. Methods: Clinical data of thirty patients diagnosed as severe acute pancreatitis in our emergency department during January 2013 and December 2017 were reviewed retrospectively. Patients were divided into the treatment group (n=l5, patients given enteral nutrition combined with microecopharmaceutics within 24 h after admission) and the control group (n=15, patients given delayed enteral nutrition after 48 h of admission). Two weeks after the treatment, the serum variables of C-reactive protein, total protein, albumin, recovery time of urine and blood amylase, length of hospital stay and APACHE II score were compared between the two groups by using paired samples t test. Results: The C-reactive protein [(46.7 ± 13.1) mg/L vs. (190.72 ± 19.3) mg/L, t=10.4, P<0.01] and APACHE II score [(7.2 ± 1.9) vs. (9.3 ± 2.4), t=2.7, P<0.05] of the treatment group were significantly lower than those in the control group. The total protein [(58.1 ± 6.3)g/L vs. (52.6 ± 5.4) g/L, t=2.5, P<0.05] and albumin [(29.9 ± 3.2)g/L vs. (22.0 ± 2.8) g/L, t=7.12, P<0.01] of the treatment group were significantly higher than those in the control group. The recovery time of urine amylase [(13.2 ± 2.1)d vs. (18.7 ± 3.9)d, t=4.9, P<0.01] and blood amylase [(7.5±3.0)d vs. (11.1 ±3.4) d, r=3.1, P<0.01], and length of hospital stay[(14.9±4.5)d vs. (27.1 ± 5.3) d, t=6.9, P<0.01] were significantly shorter in the treatment group compared with those in the control group. Conclusions: Ultra-early enteral nutrition combined with microecopharmaceutics can shorten the length of hospital stay of patients with severe acute pancreatitis, and is safe and effective. © 2018 Chinese Medical Association. All rights reserved.     

高压氧对脑梗死患者血浆SOD和CRP的影响及临床意义

Objective To study the effect of hyperbaric oxygenation(HBO) therapy on the activities of serum SOD and CRP of patients with cerebral infarction and its clinical significance. Methods 78 patients with cerebral infarction were randomly divided into hyperbaric oxygen group (HBO Group, 40 cases)and clinical group (38 cases). The clinical group was treated with clinical conventional treatment only. HBO group was treated with HBO combined with clinical conventional treatment. 21 healthy volunteers were assigned to control group. Before and after treatment, the activities of serum SOD and CRP level were measured, and the curative effect were evaluated. Results The pretreatment serum SOD and CRP of the HBO group and clinical group were significantly different from the control group (P＜ 0. 01). Compared with the pretreatment and posttreatment serum level of the HBO group, SOD raised, CRP lowered, the difference was significant(P＜ 0. 01).Compared with clinical group, SOD raised, CRP lowered and the total cure rate of the HBO group were more significant different(P ＜0.01). Conclusion HBO therapy raised the activities of SOD and lower the level of CRP in serum of the patients with cerebral infarction, and improved the free radicals scavenging ability in the body. Therefore, HBO therapy has a good effect for cerebral infarction. The experiment suggests that the activities of SOD and CRP level in serum can be used to judge the curative effect and prognosis of HBO therapy for cerebral infarction.     

依达拉奉对急性大面积脑梗死患者高敏C反应蛋白影响的临床研究

Objective To explore the effects of edaravone on high sensitivity C-reaction protein (hsCRP) in patients with acute massive cerebral infarction. Methods 86 cases with acute massive cerebral infarction were selected from December 2006 to December 2008. all the cases were divided into two groups, control group and cure group. routine treatment was used to the control group, on the basis of control group'therapy,edaravone was given to cure group. the level of hsCRP was detected before and after treatment, and the results of cure was compared. Results ①the total effective rate in two groups existed statistical difference (P<0.05);② the level of hsCRP in two groups before treatment and in the 7th and the 14th of treatment existed statistical difference(P<0.01), the level of hsCRP in the 7th and the 14th of treatment in cure group existed statistical difference(P<0.05). Conclusion Edaravone can decrease the level of hsCRP in patients with massive cerebral infarction, and has significant clinical efficacy,which should be the reference for the doctors.     

依达拉奉对急性大面积脑梗死患者高敏C反应蛋白影响的临床研究

Objective To explore the effects of edaravone on high sensitivity C-reaction protein (hsCRP) in patients with acute massive cerebral infarction. Methods 86 cases with acute massive cerebral infarction were selected from December 2006 to December 2008. all the cases were divided into two groups, control group and cure group. routine treatment was used to the control group, on the basis of control group'therapy,edaravone was given to cure group. the level of hsCRP was detected before and after treatment, and the results of cure was compared. Results ①the total effective rate in two groups existed statistical difference (P<0.05);② the level of hsCRP in two groups before treatment and in the 7th and the 14th of treatment existed statistical difference(P<0.01), the level of hsCRP in the 7th and the 14th of treatment in cure group existed statistical difference(P<0.05). Conclusion Edaravone can decrease the level of hsCRP in patients with massive cerebral infarction, and has significant clinical efficacy,which should be the reference for the doctors.     

An alveolate kidney:A case report of emphysema pyelonephritis

Rationale:Emphysematous pyelonephritis is a life-threatening infectious disease that requires early diagnosis and treatment.The disease is often misdiagnosed due to its diversity of clinical manifestations.Patient’s concern:A 62-year-old woman was admitted to the emergency department following a 12-hour history of abdominal pain and dyspnea.Physical examination showed percussion pain on the right costovertebral angle.Besides,she had a history of diabetes mellitus and urinary calculus.Diagnosis:Emphysematous pyelonephritis.Intervention:The patient accepted antishock therapy,tight glucose control,and broad-spectrum anti-infective therapy.After stabilization of the general condition,an ultrasound-guided percutaneous nephrostomy was performed.Outcome:Her conditions became stable over the following days.She presented a favorable clinical course,with normalization of renal function and positive improvements in imaging findings in a month.Lessons:Early diagnosis and rapid medical management are the keys to successful treatment.CT is an important method for the diagnosis of emphysematous pyelonephritis.For patients with severe lesions,percutaneous renal drainage combined with active anti-infection should be given in time.     

心理干预联合高压氧治疗对脑卒中后抑郁患者生命质量的影响

Objective To investigate the effect of the psychological intervention combined with hyperbaric oxygen therapy on the mental status and the quality of life of patients with depression after cerebral stroke.Methods 45 patients with depression after cerebral stroke were randomly divided into the study group (n = 22)and the control group(n = 23). The two groups had the same clinical routine treatments including improving cerebral cirulation, reducing intracranial pressure, drugs to anti-infection, nervous nutrition and corresponding operation for 8 weeks as a course of treatment, and psychological behavior intervention combined with hyperbaric oxygen therapy was added to the study group. The scores of Hamilton depression rating scale (HAMD) on both groups were evaluated before and spitzer' s quality of life index(QL-INDEX) were used and investigated on two groups at the end of 8 weeks. Results There was no significant difference on the scores of HAMD between the two groups before therapy (P ＞ 0. 05). The scores on HAMD of the study group after the treatment notably dropped compared to the control group (P＜ 0. 01). The difference of the scores on group index of quality of life between the study group (8.57 ± 1.94) and the control group (7.30 ± 1.98) had statistical significance (P ＜0. 05). Conclusion Psychological intervention combined with hyperbaric oxygen therapy plays an important role in the treatment of patient with depression after cerebral stroke to improve their mental status, treatment effectiveness and quality of life.     

康复训练结合益气中药对气虚型缺血性脑卒中患者疲劳程度的影响

目的 观察康复训练结合益气中药对气虚型缺血性脑卒中患者疲劳程度的影响.方法 将气虚型缺血性脑卒中患者90例按照随机数字法分成中药治疗组、西药对照组和空白对照组3组,每组患者30例.3组患者均采用完全相同的基础对症治疗和康复训练,中药治疗组在以上治疗的基础上增加益气活血中药汤剂进行治疗,西药对照组在基础对症治疗和康复训练的基础上增加中药安慰剂加西药进行治疗,空白对照组则在基础对症治疗和康复训练的基础上采用中药安慰剂和西药安慰剂进行治疗.3组患者均于治疗前和治疗4周后采用脑卒中专用的生活质量量表(SS-QOL)中的精力部分评定其精力,同时采用疲劳严重程度量表(FSS)评定患者的疲劳程度.结果 治疗4周后,3组患者各项评分较组内治疗前均有显著改善,差异有统计学意义(P<0.01);而中药治疗组改善情况尤为显著,与西药对照组和空白对照组治疗4周后比较,差异均有统计学意义(P<0.01).西药对照组治疗4周后其精力积分与空白对照组治疗4周后比较,差异有统计学意义(P<0.01),而疲劳程度评分2组间差异无统计学意义(P>0.05).结论 康复训练结合益气中药可显著改善气虚型脑卒中患者的精力和疲劳程度.

Abstract：

Objective To study the clinical effect of qi supplementation combined with rehabilitation on the severity of fatigue after ischcmic stroke in patients with qi deficiency. Methods Ninety ischemic stroke patients with qi deficiency were randomly divided into 3 groups of 30. The treatment group was treated with an oral decoction of qi-supplementing Chinese medicine and also rehabilitation. The Western medicine control group was treated with a Chinese medicine placebo, Western medicine and rehabilitation. The blank control group was treated with the Chinese medicine placebo and rehabilitation. All groups were evaluated using a stroke-specific quality of life scale ( SSQOL) and a fatigue severity scale (FSS) before and 4 weeks after treatment. Results After treatment, the average SS-QOL and FSS scores had improved significantly compared with those before treatment, especially in the two treatment groups. There was a significant difference between the treatment group and the Western medicine control group,and between the treatment group and the blank control group on both scales. There was also a significant difference between the Western medicine control group and the blank control group in terms of SS-QOL scores, but not FSSscores. Conclusion All 3 treatments alleviated fatigue in ischemic stroke patients with a qi deficiency. Qi supplementation combined with rehabilitation was the most effective, followed by Western medicine combined with rehabilitation.     

前列地尔干乳剂联合贝那普利对糖尿病肾病患者尿蛋白水平的影响及其不良反应

目的 探讨前列地尔干乳剂联合贝那普利对糖尿病肾病患者尿蛋白水平的影响及其不良反应。 方法 将66例糖尿病肾病患者随机分为联合组和对照组（每组33例）。对照组常规行降糖、降压、抗凝和贝那普利口服治疗,联合组在对照组的治疗基础上采用前列地尔前列地尔干乳剂治疗。比较两组疗效,治疗前、治疗2周及4周的24 h尿蛋白水平、24 h尿微白蛋白排泄率（UMER）、血肌酐水平、临床症状积分及治疗期间不良反应发生率,分析24 h尿蛋白水平与UMER、血肌酐水平及临床症状积分的关系。 结果 与对照组相比,联合组治疗显效比例、总治疗有效率提高,治疗2周及4周的24 h尿蛋白水平、UMER、血肌酐水平及临床症状积分则均降低（P<0.05）。与治疗前相比,联合组治疗2周及4周的24 h尿蛋白水平、UMER、血肌酐水平、临床症状积分降低,对照组治疗4周的24 h尿蛋白水平、UMER、血肌酐水平及临床症状积分降低（P<0.05）。两组治疗期间头痛、干咳、恶心、肝肾功能损伤等不良反应发生率差异无统计学意义（P>0.05）。Pearson相关分析显示,接受前列地尔联合贝那普利治疗的糖尿病肾病患者,其24 h尿蛋白水平与UMER、血肌酐水平、临床症状积分呈正相关（r=0.896,0.842,0.763,P<0.05）。 结论 糖尿病肾病患者尿蛋白水平与其肾功能损伤及临床症状均相关,前列地尔联合贝那普利治疗疗效和安全性良好,值得临床推广应用。       

雷公藤多苷片联合缬沙坦治疗IgA肾病蛋白尿的疗效

目的探讨雷公藤多苷片联合缬沙坦治疗IgA肾病蛋白尿的临床疗效。方法将23例原发性IgA肾病患者（24 h尿蛋白定量1.0～3.0 g.d-1）按随机数字表法分为观察组12例与对照组11例。对照组给予缬沙坦胶囊80～160 mg,1次.d-1,顿服;观察组在此基础上给予雷公藤多苷片1 mg.Kg-1.d-1,分3次口服。疗程均为3个月。比较2组治疗后24 h尿蛋白定量缓解情况。结果对照组完全缓解1例,显著缓解3例,部分缓解3例,无效4例,总有效率63.64%。观察组完全缓解3例,显著缓解5例,部分缓解4例,无效0例,总有效率100.00%。2组总有效率相比差异有统计学意义（χ2=5.282,P=0.037）。结论雷公藤多苷片联合缬沙坦治疗IgA肾病蛋白尿的临床疗效确切,能更好地降低IgA肾病患者蛋白尿水平,保护患者的肾脏功能,且不良反应少。     

环孢素联合糖皮质激素治疗IgA肾病的研究

目的观察环孢素联合糖皮质激素治疗以大量蛋白尿（蛋白尿≥3.5g/d）为主要表现的IgA肾病的临床效果。方法34例符合条件的IgA肾病患者随机入组环孢素联合激素治疗组（观察组,18例）和糖皮质激素治疗组（对照组,16例）,记录并比较两组患者治疗6个月时的24h尿蛋白定量、血清白蛋白、血清肌酐及肾小球滤过率等指标,并观察两组患者的不良反应。结果两组患者治疗6个月时的24h尿蛋白定量较治疗前显著下降（P均〈0.05）,血清白蛋白水平较治疗前显著升高（P均〈0.05）,治疗前后血清肌酐水平及eGFR水平差异均无统计学意义,且两组间总有效率的差异无统计学意义（P=0.311）。两组均无因发生不良反应而退出研究者。结论环孢素联合糖皮质激素治疗以大量蛋白尿为主要表现的IgA肾病较单纯激素治疗起效快、疗效好,且不良反应少。     

吗替麦考酚酯联合雷公藤多甙治疗IgA肾病的临床疗效观察

[目的]了解吗替麦考酚酯(MMF)联合雷公藤多甙治疗IgA肾病的临床疗效.[方法]经肾穿刺活检并结合临床确诊为原发性IgA肾病39例,随机分成两组,试验组20例,服用吗替麦考酚酯及雷公藤多甙;对照组19例,单用吗替麦考酚酯.[结果]经治疗24周后,吗替麦考酚酯联合雷公藤多甙治疗组的完全缓解率及总有效率分别为55%和85...     

P-选择素在1型糖尿病肾病大鼠发病中的作用

目的:探讨P-选择素在糖尿病肾病发病中的作用和低分子肝素法安明对肾脏保护作用及机制。方法:用链脲佐菌素(60mg/kg体重)构建1型糖尿病大鼠模型后随机分为4组,正常对照(N)组、糖尿病(DN)组、法安明大剂量治疗(T1)组、法安明小剂量治疗(T2)组。于应用法安明前、后第4、8、12周分别测定4组大鼠的体重、尿蛋白总量(24h)、尿白蛋白(24h),血肌酐;检测大鼠血P-选择素、肾组织P-选择素及P-选择素mRNA表达。结果:与N组比较,DN组大鼠肾重/体重指数以及24h尿微量白蛋白、蛋白定量、血肌酐均显著上升(P<0.05),肾组织P-选择素mRNA和蛋白表达增强(P<0.05)。与DN组比较,T1组大鼠、肾重/体重指数下降(P<0.05),T1和T2组尿蛋白量(24h)、微量白蛋白和血肌酐均显著下降(P<0.01)。T1和T2组P-选择素mRNA表达水平显著下降(P<0.01)。结论:P-选择素可能参与了糖尿病的发病过程,法安明可能通过抑制P-选择素的表达从而对肾脏有保护作用。     

黄葵胶囊联合雷公藤多苷片治疗IgA肾病

目的探讨黄葵胶囊联合雷公藤多苷片治疗Ig A肾病的临床疗效。方法将84例Ig A肾病患者按治疗方法的不同分为2组：试验组和对照组,每组42例。2组均采用常规治疗,包括降尿酸、控制血脂和抗凝治疗及控制饮食、适当的运动锻炼。在此基础上,试验组采用黄葵胶囊联合雷公藤多苷片治疗,对照组采用雷公藤多苷片治疗。观察2组治疗前和治疗12周后总胆固醇（TC）、三酰甘油（TG）、血尿素氮（BUN）、血肌酐和24 h尿蛋白定量、尿视黄醇结合蛋白（RBP）和尿2-微球蛋白（2-MG）的变化及临床疗效、不良反应的情况。结果试验组总有效率明显高于对照组（P〈0.05）。2组治疗12周后TC、TG、BUN及24 h尿蛋白定量、RBP和2-MG水平均较治疗前明显下降（P〈0.05）。治疗12周后,试验组血肌酐水平较治疗前明显下降,TC、TG、BUN及24 h尿蛋白定量、RBP和2-MG水平均较对照组明显下降（均P〈0.05）,血肌酐水平较对照组无明显变化（P〉0.05）。2组不良反应发生率比较差异有统计学意义（P〈0.05）。结论雷公藤多苷片联合黄葵胶囊治疗Ig A肾病,能够明显提高临床疗效,降低尿蛋白水平,不良反应少。     

松龄血脉康胶囊联合缬沙坦治疗高血压合并糖尿病肾病患者疗效观察及对肾功能的影响

目的探讨松龄血脉康胶囊联合缬沙坦治疗高血压合并糖尿病肾病患者疗效观察及对肾功能的影响。方法选择高血压合并糖尿病肾病患者118例,采用随机数字表法随机分为观察组59例与对照组59例。两组患者均采用常规处理。对照组给予缬沙坦治疗,观察组在对照组基础上结合松龄血脉康胶囊。两组疗程均为12周。比较两组治疗疗效,治疗前后血压、24 h尿蛋白定量和蛋白排泄率(UAER)和肾功能变化,及不良反应发生情况。结果观察组总有效率(93.22%)高于对照组(74.58%),差异有统计学意义(χ^2=7.59,P<0.05)。两组治疗后舒张压(DBP)、收缩压(SBP)、24 h尿蛋白定量、UAER、血肌酐(Scr)和尿素氮(BUN)水平较治疗前降低(t分别=16.89、20.41、10.66、23.34、19.56、13.80;11.74、10.37、5.90、12.88、8.49、8.33,P均<0.05),且观察组治疗后SBP、DBP、24 h尿蛋白定量、UAER、Scr和BUN水平低于对照组治疗后,差异均有统计学意义(t分别=6.99、6.79、9.43、8.97、11.57、9.28,P均<0.05)。观察组不良反应发生率(5.08%)低于对照组(18.64%),差异有统计学意义(χ^2=5.19,P<0.05)。结论松龄血脉康胶囊联合缬沙坦治疗高血压合并糖尿病肾病患者疗效良好,且对肾脏具有良好保护作用。     

基于“消”法理论的中药联合前列安栓治疗ⅢB型前列腺炎的疗效观察

目的探讨基于"消"法理论的中药联合前列安栓治疗ⅢB型前列腺炎的疗效观察。方法选取我院收的ⅢB型前列腺炎118例,按随机分组法分成观察组40例、对照1组39例、对照2组39例。观察组给予"消"法理论的中药汤剂联合前列安栓塞肛治疗;对照1组单纯给予中药汤剂治疗;对照2组单纯给予前列安栓塞肛治疗,疗程均为4周。对比三组治疗前后的肛门指检评分、中医症状评分、前列腺常规检测评分以及NIH-CPSI总评分。结果治疗后,三组前列腺常规检测评分比较,差异无统计学意义(P>0.05);治疗后,观察组的肛门指检评分、中医症状评分以及NIH-CPSI总评分降低明显优于对照1组、对照2组,且对照1组肛门指检评分、中医症状评分以及NIH-CPSI总评分优于对照2组,差异均有统计学意义(P<0.05);观察组治疗总有效率高于对照1组、对照2组,差异有统计学意义(P<0.05)。结论基于"消"法理论的中药汤剂联合前列安栓能改善ⅢB型CP的肛门指检症状、中医症状评分以及NIH-CPSI总评分,进而改善ⅢB型前列腺炎患者的症状,疗效可靠,安全。     

体外反搏治疗糖尿病肾病的价值

目的探讨体外反搏治疗糖尿病肾病的临床价值。方法糖尿病肾病患者216例随机分为2组,常规治疗108例为对照组,在常规治疗基础上加行体外反搏治疗108例为治疗组,对治疗前、后24h尿白蛋白和β2-微球蛋白水平进行比较。结果体外反搏治疗后,治疗组糖尿病肾病Ⅲ与Ⅳ期患者24h尿白蛋白、尿及血β2-微球蛋白较对照组明显减少(P<0.01,P<0.05),较治疗组治疗前明显下降(P<0.01,P<0.05),治疗组糖尿病肾病Ⅴ期患者治疗后与治疗前及对照组同期比较差异无统计学意义(P>0.05)。结论体外反搏治疗可降低早期糖尿病肾病24h尿白蛋白、尿及血β2-微球蛋白水平,对患者肾脏功能有保护作用。     

益气补血利水汤联合针刺治疗中风后尿潴留的临床研究

目的:探讨益气补血利水汤联合针刺治疗中风后尿潴留的临床效果。方法:将120例中风后尿潴留患者随机分为对照1组、对照2组和联合组,各40例。对照1组以常规治疗+益气补血利水汤治疗,对照2组以常规治疗+针刺治疗,联合组以常规治疗+益气补血利水汤+针刺治疗。3组患者均以14d为1个疗程,连续治疗3个疗程。治疗后比较各组患者临床疗效,比较3组治疗前后的中医症候积分、尿动力学参数,以及治疗期间不良反应发生率。结果:联合组总有效率高于对照1组、对组2组(P<0.05)。治疗后3组中医症候积分均低于治疗前,联合组中医症候积分均低于对照1组、对照2组,差异均有统计学意义(P<0.05)。治疗后,3组最大尿流量、最大逼尿肌压力、最大膀胱容量高于治疗前,残余尿量低于治疗前,联合组最大尿流量、最大逼尿肌压力、最大膀胱容量高于对照1组、对照2组,残余尿量低于对照1组、对照2组,差异均有统计学意义(P<0.05)。治疗期间3组患者不良反应发生率比较差异无统计学意义。结论:益气补血利水汤联合针刺治疗中风后尿潴留有良好的临床疗效,可改善患者临床症状和尿动力学参数,且有较好的治疗安全性,值得临床应用。